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ABSTRACT
Gait Alterations and Plantar Pressure in Diabetic Peripheral Neuropathy:
A Preliminary Study
Adrienne Dora Henderson
Department of Exercise Sciences, BYU
Master of Science
Background: Despite a lack of consensus on its utility, clinicians have traditionally relied
on plantar pressure (PP) to predict ulcer risk and prescribe interventions in individuals with
diabetic peripheral neuropathy (DPN). Joint kinematics and kinetics have the potential to
contribute to DPN assessment and treatment, however previous studies have not accounted for
walking speed nor integrated a full-body analysis with a detailed foot model.
Purpose: To assess PP and gait alterations in DPN by controlling walking speed and
incorporating a multisegment foot model into a full-body gait analysis. We hypothesize that hip
and ankle kinetics will be altered consistent with distal muscle weakness.
Methods: Ten subjects with DPN (height: 178.79 ± 8.55 cm, weight: 108.78 ± 16.67 kg,
age: 61.5 ± 13.53 years), and 10 healthy matched controls (height: 180 ± 6.37 cm, weight: 92.87
±14.5 kg, age: 59.4 ± 7.5 years) participated in this cross-sectional study. Fifty-six reflective
markers were attached to each subject according to a full-body model, including a multisegment
foot. Subjects walked at a controlled speed (1 m/s) while plantar pressure, kinematic and kinetic
data were collected. Functional data analysis was used to compare kinematic and kinetic data
between groups, while independent t-tests and a Benjamini-Hochburg procedure was used to
compare plantar pressure and joint work metrics.
Results: Individuals with DPN presented with a delayed transition from hip extension to
hip flexion moment and a decrease in peak hip flexion moment. There were no major changes
found at the knee. There was an increase in peak dorsiflexion angle and delayed power
generation in both the ankle and midtarsal joints. DPN subjects also showed a decreased
midtarsal positive work. The only significant PP metric found was a decrease in peak PP under
the lateral toes.
Conclusion: Findings demonstrated that individuals with DPN use a hip compensation
mechanism to overcome distal muscle weakness. Ankle and midfoot alterations are consistent
with muscle weakness, requiring proximal compensations. Joint mechanics were more
informative than PP measurements and may provide additional insight into DPN assessment and
treatment.
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INTRODUCTION
Diabetes mellitus is an increasingly common disease with ultimately devastating
consequences. The prevalence of diabetes mellitus has increased worldwide due to a surge in
sedentary lifestyles.1 One of the most feared long-term complications in ambulatory subjects is
eventual limb amputation resulting from unchecked foot ulcers. For patients with diabetes the
lifetime incidence of developing a foot ulcer may be as high as 25%.2 A primary cause of foot
ulcers is peripheral nerve damage or diabetic peripheral neuropathy (DPN).2,3,4 DPN causes
damage to all 3 types of nerves leading to the distal lower extremity: autonomic, sensory, and
motor.5,6,7 Damage to autonomic and sensory nerves affects sweat production and sensation,
increasing the likelihood of plantar skin trauma.7,8,9 Damage to motor nerves leads to atrophy of
intrinsic and extrinsic muscles of the foot, foot deformities, gait changes, and foot loading
changes.7,10,11 These changes can individually and collectively contribute to foot ulceration
which may lead to reduced quality of life.
Traditionally, clinicians have used plantar pressure (PP) measurements as a primary
means of predicting ulcer risk and prescribing interventions. The connection between PP and
ulcers is based primarily on a limited number of cross-sectional studies from the 1970s and
1980s which found increased PP in areas of current or previous ulcers.12 Several studies have
also shown PP differences in DPN compared to healthy controls, predominantly increased PP
under the forefoot.13,14 Interventions based on these studies include offloading devices which aim
to reduce the peak PP (PPP) by cushioning the plantar surface and/or redistributing the pressure
over a larger surface area.2 However, studies on interventions based solely off of PP have shown
mediocre outcomes2 and recent research has found only weak correlations between altered PP
and ulcer development.15,16,17 While increased PP may be a contributor to ulcer risk (eg, by
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reducing blood flow), it may not be the primary causative factor. In addition, there is still no
consensus on specific PP alterations in DPN, optimal PP measurement metrics, or altered PP
etiology.13,14,18
Additional methods of instrumented gait analysis (beyond PP) have the potential to
contribute to DPN assessment and treatment. These have been limited to use with DPN subjects
in research settings due to the expensive equipment (eg, motion capture cameras and force
plates), spatial requirements, and technical expertise needed. A number of studies have compared
DPN gait to healthy matched controls, finding several hip, knee, and ankle kinematic and kinetic
alterations. However, 17 of the 20 DPN gait studies relied on self-selected walking speeds,9,19,20
making it difficult to separate gait alterations due to speed from those due to DPN.21 Studies
using self-selected speeds have been useful in characterizing the slower, more methodical gait
used by DPN subjects.22,23 Out of the many reported gait deviations, it seems only an increase in
hip and knee flexion and a decrease in knee extensor moment production are not consistent with
decreased walking speed.21 In addition to unmatched walking speed, previous gait studies have
also been limited by modeling considerations. For instance, multisegment foot models have only
recently been used to analyze DPN foot movement during gait.22,20 While these studies have
provided valuable information about foot deviations, they have not yet been combined with fullbody analyses and have therefore been limited in identifying compensatory mechanisms. Further
understanding of DPN gait alterations and compensations may assist clinicians in providing
improved assessment and treatment.
Few studies on DPN have incorporated both PP and instrumented full-body gait analysis
in the same design. Doing this could potentially help explain changes in PP (eg, a forward shift
in weight bearing could cause an increase in PP under the forefoot) and connect DPN gait to
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measures being used in the clinic. Therefore, the overall purpose of this study is to assess PP and
gait alterations in DPN by controlling walking speed and incorporating a multisegment foot
model into a full-body gait analysis. We hypothesize that individuals with DPN will have an
increased anterior trunk lean throughout stance. This hypothesis is based on previous research
showing general muscle weakness11,24 and a sedentary lifestyle,1 as well as increased PP under
the forefoot13 and increased hip flexion during gait.25,26 We also hypothesize that individuals
with DPN will have decreased midfoot and ankle power generation in terminal stance due to
atrophy and weakness seen in the smaller distal muscles.7,10,27 As a result of this, we hypothesize
that there will be a compensatory increase in knee and hip power generation.25
METHODS
Subjects
A total of 30 participants were recruited from the local community. Due to hardware
malfunctions, data from 10 of the subjects were dropped from analysis, leaving 20 subjects for
the cross-sectional design. Ten subjects were in the initial stages of DPN (height: 178.79 ± 8.55
cm, weight: 108.78 ± 16.67 kg, age: 61.5 ± 13.53 years). The subjects were screened for and
excluded if they had a history of ulcers, amputation, any neurological condition besides DPN, or
could not walk unassisted. The other 10 subjects were age, gender and height matched
nondiabetic controls (height: 180 ± 6.37 cm, weight: 92.87 ±14.5 kg, age: 59.4 ± 7.5 years).
Exclusion criteria included a history of diabetes, any type of peripheral neuropathy, or any lower
extremity injury in the past 6 months. All subjects signed an IRB-approved informed consent
form before any data was collected.
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Protocol
Each subject’s height, weight, and date of birth was recorded after which the level of
DPN was measured using the Michigan Neuropathy Screening Instrument (MNSI).28 A total of
56 reflective markers were affixed to each subject with double-sided tape (Figure 1). Markers
were placed on the head, acromioclavicular joint line, sternum, the seventh cervical spinous
process, medial and lateral aspect of the elbow and wrist, and one marker on the hand. A marker
cluster was placed on the posterior pelvis with anterior superior iliac spine and posterior superior
iliac spine landmarks identified using a digitizing pointer. Additional clusters were used to track
the thigh and shank with individual markers on the medial and lateral aspect of the knee and
ankle. An additional 11 markers were placed on the foot the subject self-reported as most
affected by the neuropathy. A 3-segment foot model modified slightly from Bruening et al was
used29 (Figure 2). The less affected foot used 4 markers in a simple, single-segment marker set.
The more affected foot was self-reported by the DPN subjects and randomly decided by the
researchers for the controls. Subjects were brought to a carpeted walkway that lead up to the
force plate (AMTI Inc, Watertown, MA, USA) with the pressure mat (Tekscan Inc, Boston, MA,
USA) placed directly on top. The pressure mat/force plate combination was used to collect force
and pressure data simultaneously for the same foot strike (Figure 3).
Subjects were first instructed to walk down the walkway at a natural, comfortable
walking pace. Three trials were collected and used to determine each subject’s self-selected
walking speed. Next, the subjects walked down the walkway at a controlled speed of 1 m/s. This
speed is midrange for subjects with DPN according to a review article by Allet et al30 and is
similar to DPN speeds found or used by other researchers.20 A motor-driven pulley system was
used to help subjects maintain the desired speed. This consisted of a string with small colored

4

flags that was attached at each end to a plastic wheel at waist height. The plastic wheel was
calibrated to turn and pull the string at a consistent speed that the subjects could follow as they
walked down the walkway (Figure 3). Subjects were allowed to practice walking with the device
at the controlled speed until they were consistently matching it. Each subject’s starting position
was adjusted to ensure a full contact of a single foot on the pressure mat/force plate, allowing
them to walk as naturally as possible with no targeting of foot strikes.
Data Analysis
A biomechanical model of the pelvis, thigh, shank, torso, head, and upper and lower arm
segments was created according to common conventions while the 3-segment foot was made
based off the model used by Bruening et al.29 The model included a rearfoot, a mid/forefoot, and
phalanges segments which were aligned with the subject’s boney anatomy. Marker trajectories
and force data were low-pass filtered at 6 Hz and 50 Hz, respectively, and joint angles were
found based on an Euler angle rotation sequence (1-flexion/extension, 2-adduction/ abduction, 3internal/external rotation). Joint kinematics and kinetics were calculated using Visual 3D
software (C-Motion Inc, Germantown, MD, USA) for the stance phase of the controlled speed
trials only. Only sagittal plane angles were used in this study. Midtarsal kinetics were only
evaluated when the center of pressure passed anterior to the midtarsal joint.31
Whole curves were time normalized to 100% of stance and averaged across the 3 trials
for each subject. Aggregate group means and standard error bands were then plotted for
visualization. For statistical comparisons, mean between-group differences along with 95%
confidence interval bands were plotted below each curve. Regions where these confidence
interval bands separate from zero can be considered statistically significant at α = 0.05. This is an
approach that has been simplified from functional data analysis.32 A few additional gait metrics
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were extracted and compared between groups using independent t-tests (Table 3). These
consisted of positive and negative work (integral of power) performed at the ankle and midtarsal
joints.
Plantar pressure analysis consisted of metric comparisons. These consisted of the PPP
and pressure-time integrals (PTI) for 7 different foot regions (hallux, lateral toes, medial
forefoot, lateral forefoot, midfoot, medial heel, and lateral heel), the peak pressure gradients
(PPG) for 3 regions (hallux, medial forefoot, and heel), and the PPP forefoot to rearfoot ratios for
the whole foot. The 7 PPP and PTI regions were based on the default Tekscan analysis software,
while the 3 PPG regions were manually created. All PP metrics were normalized by subject
weight. Statistical comparisons were made using independent t-tests and a Benjamini-Hochberg
procedure with a false discovery rate of 0.15. This procedure was used to account for the large
number of t-tests performed in the analysis.
RESULTS
The diabetic and control groups were fairly well matched. Mass was on average 15 kg
higher in the DPN group, but this was not significant. Any potential issues due to this were
accounted for in the data processing by normalizing all PP and joint kinetics to weight. The mean
Michigan Neuropathy Screening Instrument score was 8.9 out of 13, indicating moderate DPN
progression. Seven out of 10 control subjects scored the minimum of 2, while 3 subjects
indicated mild foot discomfort.
When walking at their self-selected walking pace, the diabetic subjects walked
significantly slower than the control subjects (Table 2).33 They increased speed 7.21% in order to
match the controlled walking pace (1 m/s). Control subjects experienced an 18.74% decrease in
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order to match the controlled speed. There was no significant difference found in the controlled
speeds or time spent in stance between the 2 groups.
The DPN group had a higher dorsiflexion angle during terminal stance and during push
off (Figure 4). The DPN group also exhibited larger positive and negative peak ankle power with
a delay in transitioning from negative to positive power (Figure 4). Similar to the ankle power,
the midtarsal power graph shows a delay in the transition from negative to positive power with a
decrease in the peak positive power. Midtarsal positive work was significantly lower in DPN,
though midtarsal negative work approached significance (Table 3). The DPN group’s torso angle
also showed a slight but not significant offset throughout stance with the diabetics staying more
flexed by about 2° (Figure 5).
The hip angle graph shows an offset for almost the whole stance phase with the diabetic
group staying in a more flexed position (Figure 6). There is a large delay seen in the transition
from a hip extension to a hip flexion moment in the DPN group when compared to the control
group. The DPN group also showed a decrease in peak hip flexion moment. Hip power was
similar between groups with a mild decrease in power absorption in the DPN group (Figure 6).
There was a slight delay in the transition from knee-flexion to knee-extension moment as well as
knee power absorption (Figure 6).
The majority of the plantar pressure metrics were not found to be significant. The only
exception to this was peak pressure under the lateral toes with the higher pressure exhibited by
the control group (Table 4).
DISCUSSION
The overall purpose of this study was to assess full-body gait alterations in DPN at a
controlled walking speed. We expected to see an increase in anterior trunk lean, a decrease in
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ankle and midfoot power generation and an increase in knee and hip power generation. Our
hypotheses were only partially supported by our findings. Our results showed multiple gait
variations with only 1 (out of 18) PP alteration when walking speed was controlled.
Gait Alterations
Early Stance (initial contact through loading response). We saw very few gait differences
between groups in early stance. The knee and hip angle graphs show slight increases in flexion at
initial contact in individuals with DPN, but these are minor and not statistically significant.
Previous studies have shown that many individuals with DPN have a more cautious style of
gait,26 which results in increased lower limb flexion at initial contact. It is possible that our
subjects, who were in the initial stages of neuropathy, were not sufficiently disabled to have this
compensation strategy.
Interestingly, the diabetic group had a significant increase in MTP extension at initial
contact and through loading response (Figure 4). There seem to be 2 possible explanations for
this increase. First, the diabetic subjects could have weakness or lack of motor control of the
dorsiflexors,24 which eccentrically control the rate of plantar flexion during loading response.
Weakness of the tibialis anterior may require excessive recruitment of other dorsiflexors, such as
the toe extensors. The second possible explanation is an inability to relax the extensor hallucis
longus muscle from swing due to decreased motor control related to DPN. Additional analysis of
swing phase as well as inclusion electromyography may elucidate this mechanism.
Midstance (midstance to terminal stance). Throughout midstance, the hip appears to
compensate for distal muscle weakness. This is more apparent in the hip moment than in the
knee moment and knee/ hip powers (Figure 6). The hip extension moment is increased and
prolonged in individuals with DPN. This difference could be due to an anterior trunk lean and/or
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compensation for weakness in the posterior tibial muscles. Increased anterior trunk lean could
result in passive stretch of the hip extensor muscles, increasing tension. Although torso angle
was not found to be significantly different (Figure 6), there appeared to be a slight anterior offset
of approximately 2°, but with a large variability. Further research on the combination of anterior
pelvic tilt and anterior trunk lean with lordosis may clarify these results. Alternatively, the
altered hip moment may be a compensatory mechanism for ankle muscle weakness. Due to
reduced momentum from a weak contralateral push off (see Late Stance), the hip extensor
muscles are needed to pull the body forward, manifesting in an increased and prolonged hip
extensor moment.26
Once the body passes anterior to the ankle, the plantar flexor muscles are needed to
control anterior tibial progression.34 The dorsiflexion angle graph shows a slight increase in
angular velocity and peak dorsiflexion in early terminal stance, which suggests a minor collapse
at the ankle joint instead of a controlled roll forward.34,35 This also is a sign of weak plantar
flexors.26,36 The increase in peak dorsiflexion angle could lead to added stress on the soft tissue
around the joint (ie, power absorption). This helps explain the increase seen in the peak negative
ankle power. DiLiberto et al22 also found an increase in negative ankle power and work,
theorizing that this imbalance in power during the common task of walking could lead to midfoot
pathologies.
Late Stance (terminal stance through toe off). The push-off phase of stance in the diabetic
group suggests ankle and foot weakness along with possible sensation loss.24,37 In late stance we
saw delays in push-off as evidenced by later transitions in the hip joint moment, ankle angle, and
ankle and midtarsal powers. These could be explained by a need for individuals with DPN to
reach sufficient tissue stretch to engage compromised proprioceptive mechanisms. Despite the
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delayed ankle power generation, the positive work done at the ankle was not different between
the groups. This could be due to increased passive stretch and subsequent energy return of the
Achilles tendon. Alternatively, if this energy is being dissipated rather than stored, the late
increase in ankle power may indicate a quick delayed burst of muscle activity indicating
developing motor control issues. Either explanation points toward a weakness in ankle plantar
flexors.
Midtarsal joint mechanics show similarities to the ankle through early terminal stance,
including increased negative power. Surprisingly, there was not a concomitant increase in
midtarsal dorsiflexion with increased ankle dorsiflexion. Midtarsal power generation and
positive work done were also reduced.22 This may be due to weakness of the intrinsic foot
muscles11,37 and/or decreased engagement of the windlass mechanism. The latter is apparent in
the delayed onset of MTP extension and reduced peak angle, suggesting reduced passive power
transfer from the MTP joint to the midtarsal joint.38
Plantar Pressure
Plantar pressure was less informative than joint kinetics in identifying gait deviations in
individuals with DPN. The only significant PP difference found was a decrease in PPP under the
lateral toes in late stance. We speculate that this may be due to premature activity of the toe
extensors in preparation for swing. However, this would have to be confirmed by EMG. The lack
of additional significant findings may be related to our specific subject pool, which were in the
initial stages of DPN. However, the lack of significant PP differences in this study contrasted
with the clear kinetic differences suggest that PP is a less informative measure for DPN gait
alterations.
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Limitations and Future Research
There were several limitations in this study. First, only the stance phase of gait was
evaluated. We chose to exclude swing and focus on stance due to the possible clinical connection
to ulcer and other pathology development. In this study we used a controlled speed which may
have induced additional compensations in individuals with DPN. The chosen controlled speed of
1 m/s required individuals with DPN to speed up while requiring the control subjects to slow
down. We felt that this minimized compensations in both groups and allowed us to best isolate
the effects of DPN from walking speed. Our DPN participants were not as involved as some
previous studies. A more involved subject sample may have resulted in additional significant
differences. However, a greater degree of involvement may have had more difficulty in meeting
the task demands. We specifically targeted subjects in the initial stages of neuropathy in order to
avoid the numerous confounding effects of foot deformities and injuries, attempting to isolate
only the effects of DPN. Last, we attempted to match the demographics of the two groups,
however the age range in the DPN group was larger and the mean mass was slightly higher. A
better age match may have increased statistical power. Kinetic results were normalized to body
mass minimizing any confounding effects.
Future research could focus on longitudinal studies or on controlled walking speeds in
samples of a varying disease progression. This could help expand the picture of how gait
mechanics change with DPN over time and emphasize the changes that have already been seen.
Many of our findings were related to a possible decrease in foot and ankle strength. Future
studies could include a strength test that looks at both strength over a short period of time (ie, 1
rep max) and over a long period of time (endurance strength) in order to better understand the
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relationship between the ankle muscle strength, fatigue and the increased peak power shown in
this study.
Conclusion
This study demonstrated the need to control speed to better isolate the effects of DPN on
walking gait. Plantar pressure measures were similar between groups with the exception of a
decrease in lateral toe PPP. The gait compensations demonstrated by the DPN group seemed to
be consistent with distal muscle weakness. This is shown by the increased dorsiflexion angle and
increased negative power at the ankle and midtarsal joints and the compensatory prolonged hip
extension moment. It is also apparent in the delays in ankle angle and power, midtarsal power,
MTP angle and hip power graphs. By using a multisegment foot model in conjunction with a
traditional full-body model, we were able to identify proximal compensations for distal
weakness. The results may be useful in assessing DPN gait progression and developing
intervention protocols.

12

REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.

12.
13.
14.

15.

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010
and 2030. Diabetes Res Clin Pract. 2010;87(1):4-14. doi:10.1016/j.diabres.2009.10.007
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers. J Am Med Assoc.
2005;293(2):94-96. doi:10.1001/jama.293.2.217
Rahman MA, Aziz Z, Rajendra Acharya U, et al. Analysis of plantar pressure in diabetic
type 2 subjects with and without neuropathy. Itbm-Rbm. 2006;27(2):46-55.
doi:10.1016/j.rbmret.2006.03.001
Balducci S, Iacobellis G, Parisi L, et al. Exercise training can modify the natural history of
diabetic peripheral neuropathy. J Diabetes Complications. 2006;20(4):216-223.
doi:10.1016/j.jdiacomp.2005.07.005
Bus SA, Yang QX, Wang JH, Smith MB, Wunderlich R, Cavanagh PR. Intrinsic muscle
atrophy and toe deformity in the diabetic neuropathic foot: a magnetic resonance imaging
study. Diabetes Care. 2002;25(8):1444-1450. doi:10.2337/diacare.25.8.1444
Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other
threshold tests for preventing foot ulceration and amputation in persons with diabetes. J
Fam Pract. 2000;49(11 Suppl):S17-S29.
Nozabieli AJL, Martinelli AR, Camargo MR De, Fortaleza AC de S, Faria CRS de,
Fregonesi CEPT. Diabetic peripheral neuropathy in ankles and feet : muscle strength and
plantar pressure. Int J Diabetes Dev Ctries. 2013:9-11. doi:10.1007/s13410-013-0148-9
Patry J, Belley R, Côté M, Chateau-Degat M-L. Plantar pressures, plantar forces, and their
influence on the pathogenesis of diabetic foot ulcers: a review. J Am Podiatr Med Assoc.
2013;103(4):322-332. doi:10.7547/1030322
Rao S, Saltzman CL, Yack HJ. Relationships between segmental foot mobility and plantar
loading in individuals with and without diabetes and neuropathy. Gait Posture.
2010;31(2):251-255. doi:10.1016/j.gaitpost.2009.10.016
Hohne A, Ali S, Stark C, Bruggemann GP. Reduced plantar cutaneous sensation modifies
gait dynamics, lower-limb kinematics and muscle activity during walking. Eur J Appl
Physiol. 2012;112(11):3829-3838. doi:10.1007/s00421-012-2364-2
Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen H. Accelerated atrophy of
lower leg and foot muscles-a follow-up study of long-term diabetic polyneuropathy using
magnetic resonance imaging (MRI). Diabetologia. 2009;52(6):1182-1191.
doi:10.1007/s00125-009-1320-0
Lord M, Reynolds DP, Hughes JR. Foot Pressure Measurement: Clinical Findings. J
Biomed Eng. 1986;8(April):283-294.
Hakan T, Murat B, Sibel G, et al. The Effect of Disease Duration on Foot Plantar Pressure
Values in Patients with Type 2 Diabetes Mellitus. Turk J Phys Med Rehab.
2014;60(1):231-235. doi:10.5152/tftrd.2014.98470
Bus SA, van Deursen RW, Armstrong DG, Lewis JEA, Caravaggi CF, Cavanagh PR.
Footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar
pressure in patients with diabetes: A systematic review. Diabetes Metab Res Rev.
2016;32:99-118. doi:10.1002/dmrr.2702
Veves A, Murray HJ, Young MJ, Boulton AJM. The risk of foot ulceration in diabetic
patients with high foot pressure: a prospective study. Diabetologia. 1992;35(7):660-663.
doi:10.1007/BF00400259
13

16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.

27.
28.
29.
30.

Bacarin TA, Sacco ICN, Hennig EM. Plantar pressure distribution patterns during gait in
diabetic neuropathy patients with a history of foot ulcers. Clinics (Sao Paulo).
2009;64(2):113-120. doi:10.1590/S1807-59322009000200008
Stucke S, McFarland D, Goss L, et al. Spatial relationships between shearing stresses and
pressure on the plantar skin surface during gait. J Biomech. 2012;45(3):619-622.
doi:10.1016/j.jbiomech.2011.11.004
Mueller MJ, Zou D, Lott DJ. “Pressure Gradient” as an Indicator of Plantar Skin Injury.
Diabetes Care. 2005;28(12):2908-2912.
Savelberg HHCM, Schaper NC, Willems PJB, de Lange TLH, Meijer K. Redistribution of
joint moments is associated with changed plantar pressure in diabetic polyneuropathy.
BMC Musculoskelet Disord. 2009;10:16. doi:10.1186/1471-2474-10-16
DiLiberto FE, Tome J, Baumhauer JF, Houck J, Nawoczenski DA. Individual metatarsal
and forefoot kinematics during walking in people with diabetes mellitus and peripheral
neuropathy. Gait Posture. 2015;42(4):435-441. doi:10.1016/j.gaitpost.2015.07.012
Schwartz MH, Rozumalski A, Trost JP. The effect of walking speed on the gait of
typically developing children. J Biomech. 2008;41(8):1639-1650.
doi:10.1016/j.jbiomech.2008.03.015
DiLiberto FE, Tome J, Baumhauer JF, Quinn JR, Houck J, Nawoczenski DA. Multi-joint
foot kinetics during walking in people with Diabetes Mellitus and peripheral neuropathy. J
Biomech. 2015;48(13):3679-3684. doi:10.1016/j.jbiomech.2015.08.020
Sawacha Z, Gabriella G, Cristoferi G, Guiotto A, Avogaro A, Cobelli C. Diabetic gait and
posture abnormalities : A biomechanical investigation through three dimensional gait
analysis. Clin Biomech. 2009;24(9):722-728. doi:10.1016/j.clinbiomech.2009.07.007
Andersen H, Nielsen S, Mogensen CE, Jakobsen J. Muscle strength in type 2 diabetes.
Diabetes. 2004;53(6):1543-1548. doi:10.2337/diabetes.53.6.1543
Sacco ICN, Picon AP, Macedo DO, Butugan MK, Watari R, Sartor CD. Alterations in the
lower limb joint moments precede the peripheral neuropathy diagnosis in diabetes
patients. Diabetes Technol Ther. 2015;17(6):405-412. doi:10.1089/dia.2014.0284
Mueller MJ, Minor SD, Sahrmann SA, Schaaf J a, Strube MJ. Differences in the gait
characteristics of patients with diabetes and peripheral neuropathy compared with agematched controls. Phys Ther. 1994;74(4):299-308; discussion 309-313.
doi:10.1016/S0966-6362(98)00015-0
Severinsen K, Andersen H. Evaluation of atrophy of foot muscles in diabetic neuropathy A comparative study of nerve conduction studies and ultrasonography. Clin Neurophysiol.
2007;118(10):2172-2175. doi:10.1016/j.clinph.2007.06.019
Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening
instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg. 2006;108(5):477481. doi:10.1016/j.clineuro.2005.08.003
Bruening DA, Cooney KM, Buczek FL. Author’s personal copy Gait & Posture Analysis
of a kinetic multi-segment foot model. Part I : Model repeatability and kinematic validity.
doi:10.1016/j.gaitpost.2011.10.363
Allet L, Armand S, Golay A, Monnin D, de Bie RA, de Bruin ED. Gait characteristics of
diabetic patients: a systematic review. Diabetes Metab Res Rev. 2008;24(3):173-191.
doi:10.1002/dmrr.809

14

31.
32.
33.

34.
35.
36.
37.
38.

Bruening DA, Takahashi KZ. Partitioning ground reaction forces for multi-segment foot
joint kinetics. Gait Posture. 2018;62(February):111-116.
doi:10.1016/j.gaitpost.2018.03.001
Andrade AGP, Polese JC, Paolucci LA, Menzel HJK, Teixeira-Salmela LF. Functional
data analyses for the assessment of joint power profiles during gait of stroke subjects. J
Appl Biomech. 2014;30(2):348-352. doi:10.1123/jab.2013-0147
Fernando M, Crowther R, Lazzarini P, et al. Biomechanical characteristics of peripheral
diabetic neuropathy: A systematic review and meta-analysis of findings from the gait
cycle, muscle activity and dynamic barefoot plantar pressure. Clin Biomech.
2013;28(8):831-845. doi:10.1016/j.clinbiomech.2013.08.004
Perry J. Gait Analysis Normal and Pathological Function. Thorofare, NJ: SLACK
Incorporated; 1992.
Sacco ICN, Hamamoto AN, Gomes AA, Onodera AN, Hirata RP, Hennig EM. Role of
ankle mobility in foot rollover during gait in individuals with diabetic neuropathy. Clin
Biomech. 2009;24(8):687-692. doi:10.1016/j.clinbiomech.2009.05.003
Andersen H. Motor dysfunction in diabetes. Diabetes Metab Res Rev. 2012;28 Suppl
1(S1):89-92. doi:10.1002/dmrr.2257
Andersen H, Gjerstad MD, Jakobsen J. Atrophy of foot muscles: A measure of diabetic
neuropathy. Diabetes Care. 2004;27(10):2382-2385. doi:10.2337/diacare.27.10.2382
Bruening DA, Pohl MB, Takahashi KZ, Barrios JA. Midtarsal locking, the windlass
mechanism, and running strike pattern: A kinematic and kinetic assessment. J Biomech.
2018;73:185-191. doi:10.1016/j.jbiomech.2018.04.010

15

Table 1 Demographics Compared Between DPN and Control Groups
DPN Group
Control group
p value
Height (cm)
178.79 ± 8.55
180.00 ± 6.37
0.723
Mass (kg)
108.78 ± 16.67
92.87 ± 14.50
0.035
Age (yrs)
61.50 ± 13.53
59.40 ± 7.50
0.673
MNSI score
8.90 ± 2.47
2.40 ± 0.70
< 0.001*
* Indicates a significant difference between groups
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Table 2 Spatiotemporal Variables Compared Between DPN and Control Groups
DPN Group
Control Group
p value
Self-selected Speed (m/s)
0.91 ± 0.15
1.21 ± 0.14
< 0.001*
Controlled Speed (m/s)
0.99 ± 0.09
1.02 ± 0.06
0.308
Stance Time (s)
0.71 ± 0.06
0.73 ± 0.02
0.242
* Indicates a significant difference between groups
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Table 3 Gait Metrics Compared Between DPN and Control Groups
DPN Group
Control Group
Midtarsal Positive Work
0.08 ± 0.01
0.11 ± 0.02
Midtarsal Negative Work
−0.04 ± 0.02
−0.02 ± 0.01
Ankle Positive Work
0.13 ± 0.05
0.11 ± 0.03
Ankle Negative Work
−0.16 ± 0.17
−0.09 ± 0.05
* Indicates a significant difference between groups

p Value
0.005*
0.066
0.451
0.212
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Table 4 Plantar Pressure Metrics Compared Between DPN and Control Groups
DPN Group
Control Group
p Value
Lateral Toes PPP
1.49 ± 0.97
2.59 ± 0.65
0.011*
Medial Forefoot PPP
5.16 ± 1.83
5.13 ± 1.50
0.967
Medial Heel PPP
3.49 ± 0.77
4.34 ± 1.02
0.054
Lateral Heel PPP
3.17 ± 0.59
3.91 ± 1.01
0.064
Hallux PTI
0.52 ± 0.25
0.29 ± 0.17
0.028
Medial Forefoot PTI
0.74 ± 0.18
0.76 ± 0.28
0.841
Hallux PPG
5.96 ± 1.31
5.20 ± 3.47
0.543
Medial forefoot PPG
4.41 ± 1.68
4.77 ± 1.80
0.655
Heel PPG
4.05 ± 3.21
3.13 ± 0.80
0.390
FF/RF Ratio
1.15 ± 0.43
1.41 ± 0.40
0.195
* Indicates a significant difference between groups
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Figure 1 Full-Body Marker Set
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Figure 2 Example of Modified Foot-Marker Set
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Figure 3 Motorized Speed-Control String with Small Colored Flags on Left of Walkway
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Ankle Dorsi (+) / Plantar (-)

Midtarsal Dorsi (+) / Plantar (-)

Figure 4 Ankle and Midtarsal Angles, Moments, and Power Top row: Ankle and midtarsal
sagittal angles. Middle row : Ankle and midtarsal moments. Bottom row: Ankle and midtarsal
power. Red curves represent the DPN group, blue represent control group. Solid lines are the
group mean with shaded areas representing standard error bands. The 95% confidence interval is
plotted below to show statistical significance where it departs from 0.
23

Torso Ext (+) / Flex (-)

MTP Ext (+) / Flex (-)

Figure 5 Torso Sagittal Angle and MTP Sagittal Angle. Red curves represent the DPN group,
blue represent the control group. Solid lines are the group mean with shaded areas representing
standard error bands. The 95% confidence interval is plotted below to show statistical
significance where it departs from 0.
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Knee Ext (+) / Flex (-)

Hip Flex (+) / Ext (-)

Figure 6 Knee and Hip Angles, Moments, and Power Top row: Knee and hip sagittal angles. Middle
row: Knee and hip moments. Bottom row: Knee and hip power. Red curves represent DPN group,
blue represent control group. Solid lines are group mean with shaded areas representing standard
error bands. The 95% confidence interval is plotted below to show statistical significance where it
departs from 0.
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